RIBOCICLIB FOR RECURRENT MENINGIOMA
A Phase 0/2 study of ribociclib in preoperative Rb-positive recurrent high-grade meningioma patients scheduled for resection.
Talk to an Ivy Navigator
602-406-8605A Phase 0/2 study of ribociclib in preoperative Rb-positive recurrent high-grade meningioma patients scheduled for resection.